Form 4 for NTRA Natera, Inc.
Accepted 2024-03-07 00:00:00 ET · period of report 2024-02-29 · accession 0001415889-24-007243 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-07 | 2024-03-05 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $88.36 | -2,245 | 198.3K | -1% | -$198.4K |
| 2024-03-07 | 2024-02-29 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | A - Grant | — | +3,206 | 200.5K | +2% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-05 | S | D | 18 | $87.33 | 200,494 | D | — | — | (F3) The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1. (F4) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.31 to $87.3415 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-03-05 | S | D | 2,227 | $88.37 | 198,267 | D | — | — | (F3) The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1. |
| 3 | Common | Common Stock | 2024-02-29 | A | A | 3,206 | — | 200,512 | D | — | — | (F1) On June 10, 2022, the Reporting Person was granted performance-based Restricted Stock Units (the "RSUs") covering 12,826 shares of Common Stock vesting in tranches upon the Issuer achieving certain specified financial and operating metrics. On February 29, 2024, the achievement of milestones for the vesting of RSUs covering 3,206 shares of Common Stock was certified. (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |